Clinical Trial: MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer
Sponsor and Collaborators
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Eric Jonasch, MD M.D. Anderson Cancer Center
Next post in Kidney Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.